X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Panacea Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs PANACEA BIOTECH - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH PANACEA BIOTECH STERLING BIOTECH/
PANACEA BIOTECH
 
P/E (TTM) x -1.8 80.7 - View Chart
P/BV x 0.1 1.8 3.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 STERLING BIOTECH   PANACEA BIOTECH
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
PANACEA BIOTECH
Mar-14
STERLING BIOTECH/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs11149 7.1%   
Low Rs382 4.1%   
Sales per share (Unadj.) Rs26.884.1 31.9%  
Earnings per share (Unadj.) Rs-15.0-18.3 81.7%  
Cash flow per share (Unadj.) Rs-5.5-6.7 81.5%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.983.7 65.6%  
Shares outstanding (eoy) m267.8761.25 437.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.4 18.9%   
Avg P/E ratio x-0.5-6.3 7.4%  
P/CF ratio (eoy) x-1.3-17.2 7.4%  
Price / Book Value ratio x0.11.4 9.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,8627,074 26.3%   
No. of employees `0001.42.8 49.2%   
Total wages/salary Rs m5471,449 37.7%   
Avg. sales/employee Rs Th5,303.31,874.1 283.0%   
Avg. wages/employee Rs Th403.8527.0 76.6%   
Avg. net profit/employee Rs Th-2,959.0-407.7 725.7%   
INCOME DATA
Net Sales Rs m7,1815,154 139.3%  
Other income Rs m43100 42.7%   
Total revenues Rs m7,2235,254 137.5%   
Gross profit Rs m947-766 -123.6%  
Depreciation Rs m2,543711 357.7%   
Interest Rs m4,3771,503 291.2%   
Profit before tax Rs m-5,931-2,881 205.9%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-6 0.0%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m-1,92417 -11,454.2%   
Profit after tax Rs m-4,007-1,121 357.3%  
Gross profit margin %13.2-14.9 -88.7%  
Effective tax rate %32.4-0.6 -5,563.1%   
Net profit margin %-55.8-21.8 256.4%  
BALANCE SHEET DATA
Current assets Rs m14,3353,810 376.2%   
Current liabilities Rs m49,8098,365 595.4%   
Net working cap to sales %-494.0-88.4 558.9%  
Current ratio x0.30.5 63.2%  
Inventory Days Days403156 259.1%  
Debtors Days Days17167 253.8%  
Net fixed assets Rs m55,43214,480 382.8%   
Share capital Rs m26861 437.0%   
"Free" reserves Rs m13,935903 1,543.0%   
Net worth Rs m14,7015,127 286.7%   
Long term debt Rs m9,4785,832 162.5%   
Total assets Rs m73,98819,433 380.7%  
Interest coverage x-0.4-0.9 38.7%   
Debt to equity ratio x0.61.1 56.7%  
Sales to assets ratio x0.10.3 36.6%   
Return on assets %0.52.0 25.5%  
Return on equity %-27.3-21.9 124.6%  
Return on capital %-6.43.6 -176.7%  
Exports to sales %25.924.5 105.6%   
Imports to sales %0.210.2 1.7%   
Exports (fob) Rs m1,8601,264 147.2%   
Imports (cif) Rs m12525 2.3%   
Fx inflow Rs m1,8601,539 120.8%   
Fx outflow Rs m25942 2.6%   
Net fx Rs m1,835597 307.3%   
CASH FLOW
From Operations Rs m1,719599 286.8%  
From Investments Rs m-3,148-438 718.9%  
From Financial Activity Rs m1,426-303 -471.2%  
Net Cashflow Rs m-3-141 2.4%  

Share Holding

Indian Promoters % 33.9 74.5 45.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.6 -  
FIIs % 9.9 1.3 761.5%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 23.6 166.5%  
Shareholders   21,482 10,259 209.4%  
Pledged promoter(s) holding % 55.9 35.1 159.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   SUVEN LIFE  SHASUN PHARMA  SANOFI INDIA  TTK HEALTHCARE  SUN PHARMA  

Compare STERLING BIOTECH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Negative Note; IT Sector Down 2.4%(11:30 am)

After opening the day on a negative note, share markets in India continued to witness losses. Sectoral indices are trading on a mixed note with stocks in the IT sector.

Related Views on News

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Tata Chemicals: Profits remain flat (Quarterly Results Update - Detailed)

Nov 19, 2015

Tata Chemicals has reported consolidated topline growth of 4% YoY while the bottomline has fallen 0.8% YoY.

Tata Chemicals: Profits remain flat (Quarterly Results Update - Detailed)

Nov 19, 2015

Tata Chemicals has reported consolidated topline growth of 4% YoY while the bottomline has fallen 0.8% YoY.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Aug 18, 2017 12:52 PM

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 5-YR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS